EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota Dysbiosis in Advanced Chronic Kidney Disease and Kidney Transplantation: A Narrative Review of Pathophysiological Mechanisms, Implications for Nutritional Status, and Biotic Interventions

Cyntia Carolina García-Ramírez, Fabiola Martín-Del Campo iD, José Efrén Ortíz-González, Tonatiuh González-Heredia iD, Alfonso M Cueto-Manzano iD

Nutrients · 2026

DOI: 10.3390/nu18213502 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Cyntia Carolina García-Ramírez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Unit of Renal Disease, Specialties Hospital, Western National Medical Center, Mexican Institute of Social Security, Guadalajara 4432…. Hauptthemen laut MEDLINE: Kidney Transplantation, Dysbiosis, Nutritional Status, Gastrointestinal Microbiome. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mexican Social Security Institute, Coordinación Nacional en Salud del Instituto Mexicano del Seguro Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a serious public health issue affecting 10% of the global population. CKD is associated with intestinal dysbiosis, characterized by a reduction in saccharolytic bacteria and an increase in proteolytic genera that produce uremic toxins. This may promote intestinal barrier impairment (“leaky gut” syndrome), chronic low-grade inflammation, and protein-energy wasting (PEW), although most of the supporting evidence is observational. Kidney transplantation (KT) improves survival but may not fully reverse dysbiosis. KT recipients are exposed to residual uremia, use of perioperative antibiotics, and chronic immunosuppressive regimens. Drugs such as mycophenolate mofetil can cause gastrointestinal toxicity and reduced intake due to diarrhea or enteropathy, whereas corticosteroids and calcineurin inhibitors induce hyperphagia, hypomagnesemia, and insulin resistance. These factors may lead to a spectrum of complications ranging from persistent PEW in the early post-transplant period to a higher prevalence of weight gain and obesity, sarcopenia, and post-transplant diabetes. Furthermore, the microbiota may modulate pharmacological responses; in experimental and small clinical studies, genera such as Faecalibacterium have been linked to alterations in the metabolism of tacrolimus, potentially altering its therapeutic levels and the risk of nephrotoxicity or rejection. Interventions using biotics (prebiotics, probiotics, and synbiotics) are emerging as a potential adjuvant strategy to restore eubiosis and mitigate PEW. In non-dialysis and dialysis CKD patients, some biotics have been reported to reduce uremic toxins and inflammatory cytokines (IL-6, TNF-α), although results are heterogeneous. However, there is no evidence available regarding its ability to improve nutritional status following a KT. Safety data are limited, although biotic interventions are generally considered safe. Future prospective studies are required to confirm their efficacy and immunological safety, as well as any possible association with infectious adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationDysbiosisNutritional StatusGastrointestinal MicrobiomeRenal Insufficiency, ChronicHumansProbioticsPrebioticsImmunosuppressive AgentsAnimals

Stichwörter der Autor:innen

dysbiosisimmune toleranceintestinal microbiomekidney transplantationprebioticsprobioticssynbioticsuremic toxins

Substanzen

PrebioticsImmunosuppressive Agents

Autor:innen und Institutionen

  • Medical Research Unit of Renal Disease, Specialties Hospital, Western National Medical Center, Mexican Institute of Social Security, Guadalajara 44320, Mexico.
  • Department of Biomedical Sciences, University Center Tonala, University of Guadalajara, Guadalajara 45125, Mexico.

ORCID-Profile: Fabiola Martín-Del Campo, Tonatiuh González-Heredia, Alfonso M Cueto-Manzano

Förderung

  • Mexican Social Security Institute
  • Coordinación Nacional en Salud del Instituto Mexicano del Seguro Social

Zitieren

APA

García-Ramírez, C. C., Campo, F. M., Ortíz-González, J. E., González-Heredia, T., & Cueto-Manzano, A. M. (2026). Gut Microbiota Dysbiosis in Advanced Chronic Kidney Disease and Kidney Transplantation: A Narrative Review of Pathophysiological Mechanisms, Implications for Nutritional Status, and Biotic Interventions. Nutrients. https://doi.org/10.3390/nu18213502

Vancouver

García-Ramírez CC, Campo FM, Ortíz-González JE, González-Heredia T, Cueto-Manzano AM. Gut Microbiota Dysbiosis in Advanced Chronic Kidney Disease and Kidney Transplantation: A Narrative Review of Pathophysiological Mechanisms, Implications for Nutritional Status, and Biotic Interventions. Nutrients. 2026. doi:10.3390/nu18213502

BibTeX
@article{GarcaRamrez2026,
  author = {García-Ramírez, Cyntia Carolina and Campo, Fabiola Martín-Del and Ortíz-González, José Efrén and González-Heredia, Tonatiuh and Cueto-Manzano, Alfonso M},
  title = {Gut Microbiota Dysbiosis in Advanced Chronic Kidney Disease and Kidney Transplantation: A Narrative Review of Pathophysiological Mechanisms, Implications for Nutritional Status, and Biotic Interventions},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18213502}
}
Kostenlos starten →